Case Reports
doi: 10.1016/0165-4608(87)90364-5.
Complex translocation t(8;12;14) in a cell line derived from a child with nonendemic Burkitt-type acute lymphoblastic leukemia
- PMID: 3496952
- DOI: 10.1016/0165-4608(87)90364-5
Item in Clipboard
Case Reports
Complex translocation t(8;12;14) in a cell line derived from a child with nonendemic Burkitt-type acute lymphoblastic leukemia
Cancer Genet Cytogenet.
1987 Sep.
Abstract
A cell line is described with a typical Burkitt lymphoma (BL) marker 14q+ due to the classical reciprocal translocation between chromosome #8 and #14 with breakpoints at 8q24.1 and 14q32.3. In addition, an interstitial piece from the long arm of 12(q24.1-q24.3) is inserted at the site of the exchange on chromosome #8, proximal to 14q32.3.
Similar articles
-
Cytogenetic studies of Burkitt lymphoma-leukemia in patients with acquired immunodeficiency syndrome.Cancer Genet Cytogenet. 1988 May;32(1):67-74. doi: 10.1016/0165-4608(88)90313-5. Cancer Genet Cytogenet. 1988. PMID: 3162708
-
Translocation t(8;14)(q24;q32) and del(1)(p22) in FAB-L1 adult acute lymphoblastic leukemia with long survival.Cancer Genet Cytogenet. 1988 May;32(1):143-7. doi: 10.1016/0165-4608(88)90321-4. Cancer Genet Cytogenet. 1988. PMID: 3162704
-
Chromosome abnormalities in leukemia and lymphoma.Ann Clin Lab Sci. 1983 Mar-Apr;13(2):87-94. Ann Clin Lab Sci. 1983. PMID: 6602585
-
Recent advances in the study of B-lymphoma with 14q+ chromosome marker in Japan.Jpn J Clin Oncol. 1990 Mar;20(1):16-20. Jpn J Clin Oncol. 1990. PMID: 2181168 Review. No abstract available.
-
Acute B-cell lymphoblastic leukemia with t(14;18): establishment of a new cell line.Cancer Genet Cytogenet. 2003 Jan 15;140(2):174-5. doi: 10.1016/s0165-4608(02)00675-1. Cancer Genet Cytogenet. 2003. PMID: 12645659 Review. No abstract available.
Cited by
-
The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker.Cytotechnology. 1995 Jan;18(3):207-17. doi: 10.1007/BF00767768. Cytotechnology. 1995. PMID: 22358746
-
Frequent mutations in the amino-terminal domain of BCL7A impair its tumor suppressor role in DLBCL.Leukemia. 2020 Oct;34(10):2722-2735. doi: 10.1038/s41375-020-0919-5. Epub 2020 Jun 24. Leukemia. 2020. PMID: 32576963
-
Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells.Immunology. 1998 Nov;95(3):427-36. doi: 10.1046/j.1365-2567.1998.00615.x. Immunology. 1998. PMID: 9824507 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
